Spineway (ALSPW) - Total Liabilities
Based on the latest financial reports, Spineway (ALSPW) has total liabilities worth €6.34 Million EUR (≈ $7.41 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Spineway to assess how effectively this company generates cash.
Spineway - Total Liabilities Trend (2009–2024)
This chart illustrates how Spineway's total liabilities have evolved over time, based on quarterly financial data. Check ALSPW financial resilience to evaluate the company's liquid asset resilience ratio.
Spineway Competitors by Total Liabilities
The table below lists competitors of Spineway ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sanginita Chemicals Limited
NSE:SANGINITA
|
India | Rs468.23 Million |
|
N1 Holdings Ltd
AU:N1H
|
Australia | AU$166.62 Million |
|
HeartCore Enterprises Inc
NASDAQ:HTCR
|
USA | $9.51 Million |
|
Dom Maklerski IDM SA
WAR:IDM
|
Poland | zł1.73 Million |
|
Spacetalk Ltd
AU:SPA
|
Australia | AU$12.86 Million |
|
Aquila SA
PA:ALAQU
|
France | €5.99 Million |
|
Nandani Creation Limited
NSE:JAIPURKURT
|
India | Rs490.04 Million |
|
Da Lue International Holding Co Ltd
TWO:4804
|
Taiwan | NT$302.12 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Spineway's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALSPW stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Spineway's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Spineway (2009–2024)
The table below shows the annual total liabilities of Spineway from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €6.17 Million ≈ $7.21 Million |
-15.05% |
| 2023-12-31 | €7.26 Million ≈ $8.48 Million |
+27.58% |
| 2022-12-31 | €5.69 Million ≈ $6.65 Million |
+21.31% |
| 2021-12-31 | €4.69 Million ≈ $5.48 Million |
-0.87% |
| 2020-12-31 | €4.73 Million ≈ $5.53 Million |
-24.69% |
| 2019-12-31 | €6.28 Million ≈ $7.34 Million |
-3.16% |
| 2018-12-31 | €6.49 Million ≈ $7.58 Million |
-20.31% |
| 2017-12-31 | €8.14 Million ≈ $9.52 Million |
-0.13% |
| 2016-12-31 | €8.15 Million ≈ $9.53 Million |
+37.19% |
| 2015-12-31 | €5.94 Million ≈ $6.95 Million |
-10.22% |
| 2014-12-31 | €6.62 Million ≈ $7.74 Million |
+58.25% |
| 2013-12-31 | €4.18 Million ≈ $4.89 Million |
+11.67% |
| 2012-12-31 | €3.74 Million ≈ $4.38 Million |
+29.12% |
| 2011-12-31 | €2.90 Million ≈ $3.39 Million |
+45.87% |
| 2010-12-31 | €1.99 Million ≈ $2.32 Million |
+23.56% |
| 2009-12-31 | €1.61 Million ≈ $1.88 Million |
-- |
About Spineway
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more